Insider · CIK 0001230185
Clyde Hosein
Files at XRAY (DENTSPLY SIRONA Inc.), CRDO (Credo Technology Group Holding Ltd). First filing Jun 18, 2025, latest Jun 18, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRDO: Credo Technology Group Holding Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Credo Technology Group Holding Ltd | $157k 2,000 shares | -10% | +199% from low-7% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 11, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Common Stock | +222 | $0.00 | $0 | 40,611 | Jul 15, 2025 |
| Jun 17, 2025 | CRDO Credo Technology Group Holding Ltd | SOpen-market sale Ordinary Shares | -2,000 | $78.49 | $157k | 18,761 | Jun 18, 2025 |
| May 22, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Common Stock | +13,880 | $0.00 | $0 | 40,389 | May 27, 2025 |
| Apr 11, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Common Stock | +87 | $0.00 | $0 | 26,509 | Apr 15, 2025 |
| Jan 10, 2025 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Common Stock | +68 | $0.00 | $0 | 26,422 | Jan 14, 2025 |
| Dec 18, 2024 | CRDO Credo Technology Group Holding Ltd | AGrant or award Ordinary Shares | +4,408 | $0.00 | $0 | 20,761 | Dec 20, 2024 |
| Oct 11, 2024 | XRAY DENTSPLY SIRONA Inc. | AGrant or award Common Stock | +48 | $0.00 | $0 | 26,353 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.